Literature DB >> 17803196

PAMPA--critical factors for better predictions of absorption.

Alex Avdeef1, Stefanie Bendels, Li Di, Bernard Faller, Manfred Kansy, Kiyohiko Sugano, Yukinori Yamauchi.   

Abstract

PAMPA, log P(OCT), and Caco-2 are useful tools in drug discovery for the prediction of oral absorption, brain penetration and for the development of structure-permeability relationships. Each approach has its advantages and limitations. Selection criteria for methods are based on many different factors: predictability, throughput, cost and personal preferences (people factor). The PAMPA concerns raised by Galinis-Luciani et al. (Galinis-Luciani et al., 2007, J Pharm Sci, this issue) are answered by experienced PAMPA practitioners, inventors and developers from diverse research organizations. Guidelines on how to use PAMPA are discussed. PAMPA and PAMPA-BBB have much better predictivity for oral absorption and brain penetration than log P(OCT) for real-world drug discovery compounds. PAMPA and Caco-2 have similar predictivity for passive oral absorption. However, it is not advisable to use PAMPA to predict absorption involving transporter-mediated processes, such as active uptake or efflux. Measurement of PAMPA is much more rapid and cost effective than Caco-2 and log P(OCT). PAMPA assay conditions are critical in order to generate high quality and relevant data, including permeation time, assay pH, stirring, use of cosolvents and selection of detection techniques. The success of using PAMPA in drug discovery depends on careful data interpretation, use of optimal assay conditions, implementation and integration strategies, and education of users. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17803196     DOI: 10.1002/jps.21068

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  35 in total

Review 1.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

2.  Highly predictive and interpretable models for PAMPA permeability.

Authors:  Hongmao Sun; Kimloan Nguyen; Edward Kerns; Zhengyin Yan; Kyeong Ri Yu; Pranav Shah; Ajit Jadhav; Xin Xu
Journal:  Bioorg Med Chem       Date:  2016-12-31       Impact factor: 3.641

3.  Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.

Authors:  Cédric Lecoutey; Damien Hedou; Thomas Freret; Patrizia Giannoni; Florence Gaven; Marc Since; Valentine Bouet; Céline Ballandonne; Sophie Corvaisier; Aurélie Malzert Fréon; Serge Mignani; Thierry Cresteil; Michel Boulouard; Sylvie Claeysen; Christophe Rochais; Patrick Dallemagne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

4.  Unassisted transport of N-acetyl-L-tryptophanamide through membrane: experiment and simulation of kinetics.

Authors:  Alfredo E Cardenas; Gouri S Jas; Kristine Y DeLeon; Wendy A Hegefeld; Krzysztof Kuczera; Ron Elber
Journal:  J Phys Chem B       Date:  2012-02-22       Impact factor: 2.991

5.  A novel design of artificial membrane for improving the PAMPA model.

Authors:  Xiaoxi Chen; Anthony Murawski; Karishma Patel; Charles L Crespi; Praveen V Balimane
Journal:  Pharm Res       Date:  2008-01-10       Impact factor: 4.200

6.  Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.

Authors:  Sanghyun Lee; Xueyun Zheng; Janarthanan Krishnamoorthy; Masha G Savelieff; Hyun Min Park; Jeffrey R Brender; Jin Hoon Kim; Jeffrey S Derrick; Akiko Kochi; Hyuck Jin Lee; Cheal Kim; Ayyalusamy Ramamoorthy; Michael T Bowers; Mi Hee Lim
Journal:  J Am Chem Soc       Date:  2013-12-27       Impact factor: 15.419

Review 7.  Towards quantitative prediction of oral drug absorption.

Authors:  Jennifer B Dressman; Kirstin Thelen; Ekarat Jantratid
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

8.  Evaluation of the membrane permeability (PAMPA and skin) of benzimidazoles with potential cannabinoid activity and their relation with the Biopharmaceutics Classification System (BCS).

Authors:  M Javiera Alvarez-Figueroa; C David Pessoa-Mahana; M Elisa Palavecino-González; Jaime Mella-Raipán; Cristián Espinosa-Bustos; Manuel E Lagos-Muñoz
Journal:  AAPS PharmSciTech       Date:  2011-05-04       Impact factor: 3.246

9.  Synthesis and evaluation of 7-substituted 4-aminoquinoline analogues for antimalarial activity.

Authors:  Jong Yeon Hwang; Takashi Kawasuji; David J Lowes; Julie A Clark; Michele C Connelly; Fangyi Zhu; W Armand Guiguemde; Martina S Sigal; Emily B Wilson; Joseph L Derisi; R Kiplin Guy
Journal:  J Med Chem       Date:  2011-09-26       Impact factor: 7.446

10.  Overcoming Chloroquine Resistance in Malaria: Design, Synthesis, and Structure-Activity Relationships of Novel Hybrid Compounds.

Authors:  Aicha Boudhar; Xiao Wei Ng; Chiew Yee Loh; Wan Ni Chia; Zhi Ming Tan; Francois Nosten; Brian W Dymock; Kevin S W Tan
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.